Zitvogel L - Search Results

1

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients.

Valteau-Couanet D, Leboulaire C, Maincent K, Tournier M, Hartmann O, Bénard J, Beaujean F, Boccaccio C, Zitvogel L, Angevin E. Valteau-Couanet D, et al. Among authors: zitvogel l. Blood. 2002 Oct 1;100(7):2554-61. doi: 10.1182/blood.V100.7.2554. Blood. 2002. PMID: 12239169 Free article.

2

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Zitvogel L, et al. Nat Med. 1998 May;4(5):594-600. doi: 10.1038/nm0598-594. Nat Med. 1998. PMID: 9585234

3

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Fernandez NC, et al. Among authors: zitvogel l. Nat Med. 1999 Apr;5(4):405-11. doi: 10.1038/7403. Nat Med. 1999. PMID: 10202929

4

Dendritic cells or their exosomes are effective biotherapies of cancer.

Zitvogel L, Fernandez N, Lozier A, Wolfers J, Regnault A, Raposo G, Amigorena S. Zitvogel L, et al. Eur J Cancer. 1999 Aug;35 Suppl 3:S36-8. doi: 10.1016/s0959-8049(99)00090-8. Eur J Cancer. 1999. PMID: 10645221 Review. No abstract available.

5

[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].

Angevin E, André F, Zitvogel L. Angevin E, et al. Among authors: zitvogel l. Bull Cancer. 2000 Jan;87(1):107-15. Bull Cancer. 2000. PMID: 10673639 Free article. Review. French. No abstract available.

6

Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12).

Merad M, Angevin E, Wolfers J, Flament C, Lorenzi I, Triebel F, Escudier B, Zitvogel L. Merad M, et al. Among authors: zitvogel l. J Immunother. 2000 May-Jun;23(3):369-78. doi: 10.1097/00002371-200005000-00010. J Immunother. 2000. PMID: 10838666 Clinical Trial.

7

Dendritic cell-based immunotherapy of cancer.

Zitvogel L, Angevin E, Tursz T. Zitvogel L, et al. Ann Oncol. 2000;11 Suppl 3:199-205. doi: 10.1093/annonc/11.suppl_3.199. Ann Oncol. 2000. PMID: 11079142 Free article. Review. No abstract available.

8

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. Wolfers J, et al. Among authors: zitvogel l. Nat Med. 2001 Mar;7(3):297-303. doi: 10.1038/85438. Nat Med. 2001. PMID: 11231627

9

Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells.

Motta I, André F, Lim A, Tartaglia J, Cox WI, Zitvogel L, Angevin E, Kourilsky P. Motta I, et al. Among authors: zitvogel l. J Immunol. 2001 Aug 1;167(3):1795-802. doi: 10.4049/jimmunol.167.3.1795. J Immunol. 2001. PMID: 11466405

10

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L. Ikarashi Y, et al. Among authors: zitvogel l. J Exp Med. 2001 Oct 15;194(8):1179-86. doi: 10.1084/jem.194.8.1179. J Exp Med. 2001. PMID: 11602646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters